Undifferentiated Pleomorphic Sarcoma — Trials

Undifferentiated Pleomorphic Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

53 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20
Recruiting: 11
Ph III recruiting: 1
Growth YoY: —
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (9)

clinicaltrialsPublishedShowing 1–12 of 12 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03425279	CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma	completed	Phase 1 / Phase 2	245	BioAtla, Inc.INDUSTRY	3	Sep 23, 2025	clinicaltrials
NCT03899805	A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas	completed	Phase 2	57	Dana-Farber Cancer InstituteOTHER	1	Aug 28, 2025	clinicaltrials